APA (7th ed.) Citation

Dickinson, M. J., Minson, A., Falconer, J., Salvaris, R., Hince, D., Hawkes, E., . . . Cheah, C. (2025). 440 | GOLDILOX: FIRST EXPERIENCE OF TWO DOSING STRATEGIES OF PIRTOBRUTINIB AND GLOFITAMAB FOR MANTLE CELL LYMPHOMA PREVIOUSLY TREATED WITH COVALENT BTK INHIBITORS. Hematological oncology, 43, 1. https://doi.org/10.1002/hon.70094_440

Chicago Style (17th ed.) Citation

Dickinson, M. J., et al. "440 | GOLDILOX: FIRST EXPERIENCE OF TWO DOSING STRATEGIES OF PIRTOBRUTINIB AND GLOFITAMAB FOR MANTLE CELL LYMPHOMA PREVIOUSLY TREATED WITH COVALENT BTK INHIBITORS." Hematological Oncology 43 (2025): 1. https://doi.org/10.1002/hon.70094_440.

MLA (9th ed.) Citation

Dickinson, M. J., et al. "440 | GOLDILOX: FIRST EXPERIENCE OF TWO DOSING STRATEGIES OF PIRTOBRUTINIB AND GLOFITAMAB FOR MANTLE CELL LYMPHOMA PREVIOUSLY TREATED WITH COVALENT BTK INHIBITORS." Hematological Oncology, vol. 43, 2025, p. 1, https://doi.org/10.1002/hon.70094_440.